A Founder’s Lens | 1,428 words | 6 min read If you build anything physical, August 1, 2025, should already be circled on your calendar. That is when 30% tariffs hit select goods from Mexico and the EU. Most hardtech startups aim for margins between 40% and 60%. If you...
Business Buzz
From Free Lunch to Infrastructure: The New Economics of AI
Google’s Price Hike Signals the End of Subsidized Intelligence A Founder’s Lens | 1,227 words | 5 min read Last week, Google quietly doubled the price of Gemini Flash for API users. This was not a routine adjustment. It was a strategic signal. The era of cheap,...
Eroom’s Law or a Technopreneur in King Pharma’s Court: Part 3
A Technopreneur Lens 895 words | 3.2 minute read In Musing 1 we explored the foundation of Eroom’s Law. In Musing 2 we pirouetted our way through author reflections a decade after publication, dusted with contrasting views on trends in the cost of Drug Discovery...
Eroom’s Law or a Technopreneur in King Pharma’s Court: Part 2
Reverberation 577 words | 1.8 minute read In “The First Steps” Musing 1 we traveled Eroom’s Law, introduced in a 2012 piece for Nature Reviews Drug Discovery titled “Diagnosing the decline in pharmaceutical R&D efficiency”. Source Immense transformations in...
Eroom’s Law or a Technopreneur in King Pharma’s Court: Part 1
The First Steps 625 words | 2.1 minute read One Billion Dollars Because it was grassy and wanted wear A billion dollars doesn’t go as far in drug commercialization as it once did. Or does it? Arguments tilt each way, but it is well-defined that in seasons when...